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RESUMEN
Una dieta enriquecida con CLA mejora el daño a 
órganos asociados al síndrome metabólico en ratas 
hipertensas espontáneas.
El objetivo del presente estudio fue proporcionar eviden-
cia que el CLA dietario puede evitar la patogénesis del sín-
drome metabólico en la estructura tisular, lo que sugiere be-
neficios potenciales en el desarrollo de este síndrome. Dos 
grupos de ratas Wistar macho espontáneamente hipertensas 
(SHR) fueron alimentadas con una dieta normal por 8 sema-
nas: una dieta contenía 7.5% de aceite de girasol (grupo VS-
HR), y el otro contenía 6% de aceite de girasol y 1.5% de 
CLA (grupo CLA-SHR). A un grupo testigo sano de ratas ma-
cho Kyoto-Wistar les fue proporcionada una dieta normal con 
7.5% de aceite de girasol. Los animales fueron sacrificados y 
se tomaron secciones de hígado, riñones y aorta, las cuales 
fueron fijadas en formaldehído al 10% y teñidas con Hema-
toxilina y Eosina. Las tinciones de aorta mostraron morfolo-
gía irregular del endotelio en la aorta solo en el grupo V-SHR; 
el parénquima hepático se caracterizó por infiltración de neu-
trófilos inflamatorios, fibrosis y engrosamiento del epitelio de 
la vena porta, hiperplasia hepática y esteatosis. El tejido re-
nal de este mismo grupo evidenció hiperplasia en las células 
del endotelio de la cápsula de Bowman. No se observaron 
cambios anormales histológicos tanto en el grupo testigo co-
mo en el alimentado con CLA, lo que sugiere un papel pro-
tector del CLA en el desarrollo del síndrome metabólico.
PALABRAS CLAVE: Ácido linoléico conjugado – Disfun-
ción endotelial – Esteatosis – Síndrome metabólico – Resis-
tencia a la insulina. 
SUMMARY
A CLA enriched diet improves organ damage 
associated with the metabolic syndrome in spontaneous 
hypertensive rats.
The purpose of this study was to provide evidence that 
dietary CLA can prevent the pathogenesis of metabolic 
syndrome in tissue structure, suggesting potential benefits 
in the onset of this syndrome. Wistar male spontaneous 
hypertensive rats (SHR), were classified into two groups 
that were fed a standard diet for eight weeks: one with 7.5% 
sunflower oil (V-SHR group), and the other with 6% sunflower 
oil and 1.5% CLA (CLA-SHR group). A control healthy group 
consisted of Kyoto-Wistar male rats fed the standard diet with 
7.5% sunflower oil. The animals were sacrificed, and sections 
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of liver, kidneys and aorta were fixed in 10% formaldehyde, and 
then stained with Hematoxylin and Eosin. Only in the V-SHR 
group, the stain of the aorta indicated irregular endothelial 
morphology; liver parenchyma was characterized by an 
infiltration of inflammatory neutrophils, fibrosis, thickening 
of the portal vein epithelium, hepatocyte hyperplasia and 
steatosis. The renal tissue of this group evidenced hyperplasia 
in the cells of the endothelial of Bowman´s capsule. Abnormal 
histological changes were not observed in either the control 
group or the rats fed with CLA, suggesting a protective role of 
CLA in the onset of metabolic syndrome. 
KEY-WORDS: Conjugated linoleic acid – Endothelial 
dysfunction – Insulin resistance – Metabolic syndrome – 
Steatosis.
1. INTRODUCTION
Reaven (1998) first introduced the concept of 
syndrome X or metabolic syndrome (MS); which he 
described as a cluster of abnormal glucose tolerance or 
diabetes, dyslipidemia (low HDL cholesterol, high 
total triglycerides), obesity, insulin resistance and 
elevated blood pressure. Recently, several other 
metabolic disturbances that are more frequently found 
in combinations rather than isolated in individuals with 
MS have been included (Lamarche & Desroches 
2004). Thus, an increased number of reduced size LDL 
particles, impaired fibrinolytic activity, a pro-inflammatory 
state, impaired postprandial metabolism, abdominal 
obesity, and a pro-oxidative state were all considered 
as important features of MS (Reaven, 2002). 
It has been established that insulin is an anti-
inflammatory hormone, so an impairment causing 
an insulin resistance promotes the activation of 
some pro-inflammatory transcription molecules 
such as the intra-nuclear factor (NF)-kB, early 
growth response-1 (Egr-1) and activating protein-1 
(AP-1) (Aljada et al., 2002). Similarly, obesity has 
been associated to inflammation. This association 
was first proposed by Hotamisligil and co-workers 
(1993), who found that the tumor necrosis factor-α 
(TNF-α) was over expressed in the adipose tissue of 
obese mice. TNF-α is a pro-inflammatory cytokine 
that can activate various cascades, including many 
of the pathways that control insulin activity.
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J.T. Baker (Mexico City). Dietary components were 
purchased from Harlan Teklad Inc. (Mexico City). 
2.2. Experimental design
Ten male Kyoto-Wistar (KW) and 16 SHR 
(spontaneously hypertensive rats), all nearly 
21 days old, were purchased from Harlan Teklad 
Inc. (México City). Animals were individually 
housed in stainless-steel cages and maintained in 
12-h light/dark cycles at 25°C. Animal maintenance 
and handling were done in accordance with the 
National Institutes of Health guide for the Care 
and Use of Laboratory Animals (1985). The rats 
were divided into two groups: the KW rats as the 
normotensive control group (n =10) and the SHR 
as the MS group (n = 16). Both groups received a 
standard diet (Lab Diet 2001, Harlan Teklad) for 2 
weeks. Then, the spontaneously hypertensive rats 
(SHR) were divided into two groups: a sunflower 
oil group (V-SHR; n = 8), and a CLA mix group 
(CLA–SHR; n = 8). The V-SHR group received a 
diet with 7.5% sunflower oil (Patrona brand, from 
the local market) and the CLA–SHR group received 
a diet with 6 % sunflower oil and 1.5 % of CLA 
(Lipid Nutrition; Clarinol A-95) as lipid source. The 
control group (KW; n=10) received the sunflower 
oil diet; the three groups received the experimental 
diets depicted in Table 1 for 8 weeks. Diets were 
prepared including 0.02% BHT as antioxidant and 
stored under refrigeration until used.
2.3. Blood pressure measurement
At the end of the experimental diet period, body 
weight and systolic blood pressure were measured by 
a tail-cuff method (IITC) noninvasive blood pressure 
system, model 29; Life Science Instruments (Woodland 
Hills, CA).
2.4. Analytical Methods
Blood samples from 18-hour fasted animals were 
carefully collected from the tail tip, and centrifuged 
at 1086xg for 10 min. Serum samples were 
kept at –20°C for further analysis. Serum glucose 
concentration was measured by the glucose oxidase 
method (Barham & Trinder 1972). Total cholesterol 
and triglycerides were quantified using an enzymatic 
assay (Assmann, 1979). 
2.5. Microscopic analysis of tissues
To assess tissue damage, slices of each organ 
were fixed for 24 h in 10% neutral buffered formalin. 
Sections (4-6 µm) of the tissues were embedded in 
paraffin, and stained with hematoxylin and eosin (H-
E) prior to microscopic examination (Bayliss, 1990) 
Images were obtained using an Olympus BX51 
microscope equipped with a Camedia C3040zOOM 
digital camera (Olympus America, Melville, NY). All 
the images were taken at 50X enlargement.
Other factors are also associated with the 
increased incidence of MS; for example, the amount 
of food that is consumed by a single person today is 
far greater than before; furthermore, large portions 
of the average diet of humans consist of fast foods 
and may not contain enough fiber (Dandona et al., 
2005). Because resistance to insulin also results in 
the relative non-suppression of adipocyte hormone–
sensitive lipase, there is a further enhancement of 
lipolysis and increased FFA concentration. Thus, 
a vicious circle of lipolysis, increased FFA, insulin 
resistance, and inflammation is formed (Dandona 
et al., 2005; Roche, 2005; Phillips et al., 2008).
Conjugated linoleic acid (CLA) is a mixture of 
positional and geometric isomers of linoleic acid 
(octadeca-9:12-dienoic acid). The major dietary 
sources of CLA for humans are beef and dairy 
products; beef tallow contains ~0.5% of fatty acids 
as CLA (Ohnuki et al., 2001). CLA has attracted 
considerable attention over the past few years 
because of its beneficial biological effects, including 
protective roles against several types of cancers, 
atherosclerosis, and obesity (Chin et al., 1992; 
Nicolosi et al., 1997; Terpstra, 2004; Mullen et al., 
2007). One of the major risk factors for metabolic 
syndrome is diabetes, which has been tested in 
animal models. In this regard the antidiabetic effects 
of CLA have been examined in animal models like 
zucker diabetic fatty (zDF), fa/fa rats, which exhibit 
obesity and hyperglycemia at an age of 7-8 weeks. 
Feeding with 1.5% of CLA for 14 days normalized 
impaired glucose tolerance and attenuated fasting 
hyperinsulinemia and free fatty acid concentrations 
(Nagao et al., 2003).
The purpose of this study was to provide evidence 
that dietary CLA prevents the pathogenesis of MS 
on tissue structure, suggesting potential benefits in 
the onset of this condition.
2. MATERIALS AND METHODS
2.1. Materials
All chemicals were of analytical grade, obtained 
from Sigma (St. Louis, MO), Bayer (Mexico City) and 
Table 1
Composition of the experimental diets fed  
to the rats
Ingredients 
KW and 
V-SHR Diet 
(g)
CLA–SHR
Diet 
(g)
Casein
DL-Methionine
Cellulose
Corn starch
Vitamin mixture
Mineral mixture
BHT
Sunflower oil
CLA mix
440
3.1
40
658
20
80
0.4
100
–
440
3.1
40
658
20
80
0.4
80
21.5
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Blood pressure was measured in animals before 
and after the experiment to assess the effect of 
the diets. At the beginning of the experiment, the 
systolic blood pressure value was similar in the 
three groups (see Table 3). However, at the end 
of the 8 weeks of treatment, statistical differences 
were found. The CLA-SHR rats showed a decrease 
in systolic blood pressure with respect to the group 
of rats fed only sunflower oil diet (see Table 4).
3.2. Microscopic tissue analysis
Figure 1, panels A through C, depicts the changes 
in the aorta in the groups KW, V-SHR and CLA-SHR. 
The H-E stain suggests proliferation of elastic fibers 
and collagen in the intimae and middle layers in the 
V-SHR group, compared to the control group. It was 
observed that samples from the CLA-SHR group 
had a positive change in the endothelium. Figure 2, 
panels D to g, shows liver parenchyma from the KW 
and CLA-SHR group, respectively. An infiltration of 
inflammatory neutrophils, the presence of globose 
hepatocytes and steatosis, characterized by fat-filled 
hepatocytes (panels E and F) were clearly noted in 
the V-SHR group.
The cortical portion of the renal tissue can be 
identified in Figure 3, panels H to J. It is characterized 
by the presence of renal glomeruli (rg) surrounded 
by the endothelium forming Bowman’s capsule (bc). 
In Figure 3, panel I, the renal tissue of all animals 
from group V-SHR showed hyperplasia in the cells 
of the endothelial of Bowman’s capsule.
4. DISCUSSION
This study showed that a daily supplementation 
of the diet with sunflower oil lead to a significant 
elevation of glucose, cholesterol and triglyceride 
2.6. Data analysis
Data are presented as the mean ±SD. Statistical 
significance was determined by ANOVA, and 
Tukey’s multiple range test was used for mean 
comparison (p<0.05).
3. RESULTS 
3.1.  Body weight, biochemical measurements 
and blood pressure
Table 2 shows the differences in body weight as 
well as food intake at the start and after the eight 
weeks of experimental treatment with sunflower 
oil and conjugated linoleic acid (CLA-SHR). The 
rats with sunflower oil (V-SHR) administration 
showed an increase in body weight and in food 
consumption (378.30±16.67 g and 9.61±0.30 g/
day/100 g bw, respectively) (p<0.05) with respect to 
the control group Kyoto-Wistar (KW) (312.09±17.61 
g and 5.18±0.70 g/day/100 g bw, respectively) 
(p<0.05). On the other hand, the rats with (CLA-
SHR) only showed a significant difference in body 
weight (345.36±11.70 g) (p<0.05) with respect to 
the control group (KW).
Regarding the profile of serum parameters, Table 
3 depicts the concentrations of glucose, cholesterol 
and triglycerides in the three experimental groups. 
The values between groups were no different before 
the experiment. However, after 8 weeks, in the 
CLA-SHR rats the concentration of serum glucose 
(91.05±1.13 mg/dL), cholesterol (42.68±1.77 mg/dL) 
and triglycerides (33.00±2.14 mg/dL) were significantly 
lower than in the KW (glucose, 122.0±5.27 mg/
dL; cholesterol 75.67±4.46 mg/dL and triglycerides 
108.25±4.24 mg/dL) and V-SHR (glucose 165.03±1.86 
mg/dL; cholesterol 94.46±1.99 mg/dL and triglycerides 
136.39±2.08 mg/dL) groups (see Table 4).
Table 2
Body weight and food intake in rats fed experimental diets for eight weeks
KW  V-SHR CLA-SHR
Food consumption (g/day/100 g bw. 5.18±0.70a 9.61±0.30b 5.50±0.04a
Weight after eight weeks/g) 312.09±17.61a 378.30±16.67b 345.36±11.70c
 bw=body weight. Values represent the mean ±S.D. Means in the same row with the same superscript are statistically similar (p<0.05).
 Table 3
Biochemical parameters and blood pressure in rats before the experiment
Animal group KW n=10 SHR* n=16
glucose (mg/dL) 136.15±8.96a 135.96±14a
cholesterol (mg/dL) 49.30±4.21a 40.97±4.09b
triglycerides (mg/dL) 85.74±3.07a 109.30±9.50 b
systolic blood pressure (mm Hg) 133.4±9.52a 196.8±12.78 b
KW=Kyoto Wistar; *Refers to rats to be fed both the sunflower diet and (V-SHR) and conjugated linoleic acid (CLA-SHR) diets. Values 
represent the mean ±S.D. Means in the same row with the same superscript are statistically similar (p<0.05).
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development of atheroma in animals of the CLA-SHR 
group (see Figure 1 panel C).
Moreover, the pathogenesis observed in 
liver parenchyma of the experimental animals 
fed with vegetable oil (Figure 2, panels E and F) 
was characterized by an infiltration of inflammatory 
neutrophils. Different etiological factors have been 
proposed, so that an increase in liver mitochondrial 
oxidation by free fatty acids may cause oxidative stress 
(Kumar et al., 2006). This process is characterized 
by the production of nitric oxide by the inflammatory 
cells present in liver parenchyma that enlarge the 
endothelium and promote smooth muscle relaxation. 
This event decreases blood circulation into the liver 
cells. In the same way, the oxidative stress promotes 
the formation of peroxides in the lipids of the cellular 
membrane, thus affecting its viscosity (Karninski, 
2004). In the rest of the parenchyma it is possible 
to assess the presence of globose hepatocytes (gh) 
(panel E). Additionally, fibrosis, thickening of the portal 
vein epithelium (pv), hepatocyte hyperplasia and 
steatosis (s), characterized by fat-loaded hepatocytes 
(panels E and F) were noted.
Histological analysis performed on samples of 
animals fed with CLA (Figure 2, panel g) shows 
the absence of steatosis in liver tissue. Recent 
data obtained by Moloney and co-workers (2007a) 
showed that the intake of dietary CLA normalized 
insulin levels, and suggested an alternative mechanism 
for reduced levels of triglycerides. This was probably 
due to a decline in insulin production to prevent the 
re-esterification of free fatty acids into triglycerides 
concentrations. These findings clearly support the 
atherogenic properties of saturated fatty acid which 
were previously demonstrated by Bayindir and co-
workers (2002). The morphological examination 
of the aorta of the V-SHR group revealed major 
alterations related to hyperlipidemia, including irregular 
endothelium morphology and growth of fibrous tissue. 
It has been recognized that the endothelial cells 
release nitric oxide that relaxes the muscle cell of the 
blood vessel wall, by allowing blood to flow more freely 
(Cohen, 1995; Wilson et al., 2006). Fatty acids such 
as eicosa-5:8:11:14-tetraenoic acid (arachidonic acid) 
regulates and reduces nitric oxide synthesis, thereby 
fostering an inadequate transit of substances through 
the endothelium. This may explain the presence of 
fibrous tissue in the endothelium of the aorta of the 
group V-SHR (see Figure 1, panel B).
It has been shown that an intake of polyunsaturated 
fatty acids such as CLA in the diet of animals with 
MS exerted a positive effect on the symptoms of 
the MS. Lee and co-workers (1994) reported that 
CLA increased the functionality and decreased the 
cellular state for insulin resistance. This assertion 
suggests the absence of an atherogenic process in 
the aorta of the animals fed CLA, as shown in the 
CLA-SHR group in Figure 1 (panel C). Similarly, 
Alexander and co-workers (2004) reported that n-3 
PUFA induced structural changes that improved the 
physico-chemical properties of the membrane of 
the adipocites by increasing its fluidity and viscosity 
in hypertensive rats. These structural changes of 
the membrane, could account for the limited 
Table 4
Biochemical parameters and blood pressure in rats after the experiment
Animal group KW n=10 V-SHR n=8 CLA-SHR n=8
glucose (mg/dL) 122.00±5.27a 165.03±1.86b 91.05±1.13c
cholesterol (mg/dL) 75.67±4.46a 94.46±1.99b 42.68±1.77c
triglycerides (mg/dL) 108.25±4.24a 136.39±2.08b 33.00±2.14c
systolic blood pressure (mm Hg) 142.00±6.32a 222.88±12.32b 160.00±8.16c
KW=Kyoto Wistar; sunflower diet and (V-SHR) and conjugated linoleic acid (CLA-SHR) diets. Values represent the mean ±S.D. Means in 
the same row with the same superscript are statistically similar (p<0.05).
Figure 1
Effects of experimental diets on aorta. (A): normal 
cytoarchitecture of aorta in the control group (KW); (B): 
proliferation of collagen fibers (cf) in the intimal (i) and media 
(m) layers in the V-SHR group; (C): absence of pathological 
alterations in the intimal (i), media (m) and adventitious (a) 
layers of the CLA-SHR group. Staining was done with 
hematoxylin-eosin and enlargement was 50X (bar= 60 µm).
Figure 2
Effects of experimental diets on liver. (D): normal cytoarchitecture of 
the portal vein (pv) and the rest of parenchyma (p) of the hepatic 
tissue in the KW group; (g): normal parenchyma (p) in the CLA-SHR 
group. (E): an inflammatory process (ip) as well as globose 
hepatocytes (gh) in the V-SHR group; (F): steatosis and hyperplasia 
of the hepatocytes in the same V-SHR group. Staining was done with 
hematoxylin-eosin, and enlargement was 50X (bar = 60 µm).
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5. CONCLUSION
This study demonstrated that intervention with 
a CLA enriched diet significantly reduced biochemical 
parameters, improved irregular endothelial morphology, 
reduced liver damage and prevented the hyperplasia of 
renal cells in rats with MS.
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Staining was done with hematoxylin-eosin and enlargement 
was 50X (bar= 60 µm).
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